HealthQuartzabout 2 hours ago
Ipsen buys Kartos for 1.75 billion
1 min read
Pharmaceutical company Ipsen acquires United States-based biotechnology firm Kartos Therapeutics in a deal valued at up to one point seven five billion dollars. The transaction expands Ipsens oncology portfolio by adding blood cancer treatments developed by the smaller startup entity.
Level
Hype check
Tap to vote and see what everyone thinks.